Conversion Surgery for Locally Unresectable Pancreatic Cancer - International Multi-center Observational Trial (ROBIN= suRgery for lOcally unresectaBle pancreatIc Cancer)
Pancreatic cancer is a severe disease often diagnosed at an advanced stage, when surgery is not possible. New chemotherapy treatments can sometimes shrink the tumor and make surgery an option. This study aims to understand if surgery after such treatments can improve survival and quality of life in selected patients treated at expert centers.
• Patients older than 18 years
• Patients able to give informed consent
• Histologically confirmed pancreatic adenocarcinoma
• LAPC stage according to NCCN10 at diagnosis (Figure 1)
• Received at least 4 months of induction chemotherapy
• RECIST 1.1 stable disease (SD) or partial response (PR) after induction therapy
• Patient considered eligible for radical resection by local MDT